Thomas G. Keens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Thomas G. Keens has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Sally L. Davidson Ward
Children’s Hospital Los Angeles
5 shared publications - Iris Ambrosio Perez
Keck School of Medicine of University of Southern California, Los Angeles, USA
4 shared publications Sheila S. Kun
Children’s Hospital Los Angeles
3 shared publications- Anita Sicolo
Children’s Hospital Los Angeles, Los Angeles, USA
2 shared publications - Jaya Punati
Children’s Hospital Los Angeles, Los Angeles, USA
2 shared publications - Keshawadhana Balakrishnan
Texas Children’s Hospital, Houston, USA
2 shared publications
Latest Publications
- 20 December 2024
- Published by Springer Nature
- p. 397-412
Prolonged Home Mechanical Ventilation: A Nursing Perspective
- 20 December 2024
- Published by Springer Nature
- p. 397-412
Prolonged Home Mechanical Ventilation: A Nursing Perspective
- 15 December 2021
- Published by Wiley in Pediatric Pulmonology
- Vol. 57 (3) , 682-685
Does acute flaccid myelitis cause respiratory failure in children?
Introduction: Acute flaccid myelitis (AFM) is a rare disease that affects spinal cord gray matter, results in acute flaccid weakness of one or more limbs and predominantly involves the cervical spinal cord, which places patients at higher risk for respiratory failure. Our study aims to describe respiratory failure in pediatric AFM patients with emphasis on the need for assisted ventilation and respiratory nerve involvement from an acute and long‐term perspective.Materials and Methods: We reviewed the medical records of patients diagnosed with AFM seen in a multidisciplinary clinic for persistent limb weakness between 2016 and 2020.Results: We studied 54 patients, 35% were female. The median age of patients at illness onset was 5 years (range 7 months−19 years). The median age of patients at the time of study was 8.5 years (range 2−20 years). Eleven patients (20%) required assisted ventilation for acute respiratory failure. Of those that experienced acute respiratory failure, 81% developed chronic respiratory failure. Fifty‐six percent of patients with chronic respiratory failure were able to wean off assisted ventilation by 1 year. All patients that experienced unilateral diaphragm impairment with AFM onset experienced acute and chronic respiratory failure.Discussion: Many patients with AFM may experience respiratory compromise and develop chronic respiratory failure. However, most of these patients can be weaned off ventilatory support by 1 year from illness onset. Most children with unilateral diaphragm impairment can sustain adequate ventilation without the need for long‐term ventilatory support.
- 15 December 2021
- Published by Wiley in Pediatric Pulmonology
- Vol. 57 (3) , 682-685
Does acute flaccid myelitis cause respiratory failure in children?
Introduction: Acute flaccid myelitis (AFM) is a rare disease that affects spinal cord gray matter, results in acute flaccid weakness of one or more limbs and predominantly involves the cervical spinal cord, which places patients at higher risk for respiratory failure. Our study aims to describe respiratory failure in pediatric AFM patients with emphasis on the need for assisted ventilation and respiratory nerve involvement from an acute and long‐term perspective.Materials and Methods: We reviewed the medical records of patients diagnosed with AFM seen in a multidisciplinary clinic for persistent limb weakness between 2016 and 2020.Results: We studied 54 patients, 35% were female. The median age of patients at illness onset was 5 years (range 7 months−19 years). The median age of patients at the time of study was 8.5 years (range 2−20 years). Eleven patients (20%) required assisted ventilation for acute respiratory failure. Of those that experienced acute respiratory failure, 81% developed chronic respiratory failure. Fifty‐six percent of patients with chronic respiratory failure were able to wean off assisted ventilation by 1 year. All patients that experienced unilateral diaphragm impairment with AFM onset experienced acute and chronic respiratory failure.Discussion: Many patients with AFM may experience respiratory compromise and develop chronic respiratory failure. However, most of these patients can be weaned off ventilatory support by 1 year from illness onset. Most children with unilateral diaphragm impairment can sustain adequate ventilation without the need for long‐term ventilatory support.
- 5 January 2021
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 180 (2) , 475
Correction to: Hirschsprung disease and other gastrointestinal motility disorders in patients with CCHS
- 5 January 2021
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 180 (2) , 475
Correction to: Hirschsprung disease and other gastrointestinal motility disorders in patients with CCHS
- 28 October 2020
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 180 (2) , 469-473
Hirschsprung disease and other gastrointestinal motility disorders in patients with CCHS
Congenital central hypoventilation syndrome (CCHS) is an autonomic nervous system dysfunction due to PHOX2B gene mutation. Little is known about gastrointestinal motility disorders in CCHS patients. This study aims to describe the spectrum of gastrointestinal motility disorders in CCHS and provide PHOX2B genotype-phenotype correlation with Hirschsprung Disease (HD). We reviewed the records of 72 CCHS patients seen at Children’s Hospital Los Angeles from 1999 to 2019. Data collected included demographics, PHOX2B genotype, ventilator dependence, medical and surgical history, and gastrointestinal motility studies. Of the 72 patients, 31% had HD, 50% females, and 60% had 20/27 PARM. Rectosigmoid HD formed 73% of the cases whereas long segment (up to splenic flexure involvement) forms represented 23%. Four patients had total colonic aganglionosis, including one patient with 20/25 PARM genotype. One HD patient was identified with colonic myopathy in the residual segment. One patient was found to have achalasia type 1. Conclusion: Nearly one third of our CCHS patients had HD. Although most had 20/27 PARM, 2 patients had 20/25 PARM. Thus, CCHS patients with constipation are at risk for HD regardless of genotype. Colonic myopathy may coexist in treated HD with refractory constipation. Achalasia may occur in patients with CCHS. What is Known: • Patients with CCHS have motility disorders and present with esophageal dysmotility and constipation as a manifestation of their autonomic nervous system dysfunction. • About 20% of patients with CCHS have Hirschsprung disease and previously described to be associated with NPARM and 20/27 PARM genotype. What is New: • Thirty-one percent of CCHS patients in our series have Hirschsprung disease (HD). • HD, including the more severe total colonic aganglionosis was found in a patient with 20/25 PARM genotype suggesting that CCHS patients with constipation should be screened for HD regardless of genotype.
- 28 October 2020
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 180 (2) , 469-473
Hirschsprung disease and other gastrointestinal motility disorders in patients with CCHS
Congenital central hypoventilation syndrome (CCHS) is an autonomic nervous system dysfunction due to PHOX2B gene mutation. Little is known about gastrointestinal motility disorders in CCHS patients. This study aims to describe the spectrum of gastrointestinal motility disorders in CCHS and provide PHOX2B genotype-phenotype correlation with Hirschsprung Disease (HD). We reviewed the records of 72 CCHS patients seen at Children’s Hospital Los Angeles from 1999 to 2019. Data collected included demographics, PHOX2B genotype, ventilator dependence, medical and surgical history, and gastrointestinal motility studies. Of the 72 patients, 31% had HD, 50% females, and 60% had 20/27 PARM. Rectosigmoid HD formed 73% of the cases whereas long segment (up to splenic flexure involvement) forms represented 23%. Four patients had total colonic aganglionosis, including one patient with 20/25 PARM genotype. One HD patient was identified with colonic myopathy in the residual segment. One patient was found to have achalasia type 1. Conclusion: Nearly one third of our CCHS patients had HD. Although most had 20/27 PARM, 2 patients had 20/25 PARM. Thus, CCHS patients with constipation are at risk for HD regardless of genotype. Colonic myopathy may coexist in treated HD with refractory constipation. Achalasia may occur in patients with CCHS. What is Known: • Patients with CCHS have motility disorders and present with esophageal dysmotility and constipation as a manifestation of their autonomic nervous system dysfunction. • About 20% of patients with CCHS have Hirschsprung disease and previously described to be associated with NPARM and 20/27 PARM genotype. What is New: • Thirty-one percent of CCHS patients in our series have Hirschsprung disease (HD). • HD, including the more severe total colonic aganglionosis was found in a patient with 20/25 PARM genotype suggesting that CCHS patients with constipation should be screened for HD regardless of genotype.
- 11 February 2020
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 179 (7) , 1173
Correction to: Life-threatening cardiac arrhythmias in congenital central hypoventilation syndrome
The publisher regrets that in the original published version of this article, one of the author’s name was incorrectly presented as “Yaniv Bar Cohen”. The correct presentation should have been “Yaniv...
- 11 February 2020
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 179 (7) , 1173
Correction to: Life-threatening cardiac arrhythmias in congenital central hypoventilation syndrome
The publisher regrets that in the original published version of this article, one of the author’s name was incorrectly presented as “Yaniv Bar Cohen”. The correct presentation should have been “Yaniv...
- 19 February 2018
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- Vol. 12 (4) , 283-292
Congenital central hypoventilation syndrome: diagnosis and management
Introduction: Congenital central hypoventilation syndrome (CCHS) is a rare disorder defined by a failure in autonomic control of breathing secondary to mutations of the PHOX2B gene. Affected individuals demonstrate absent or diminished physiologic response to hypercapnia and hypoxia that is most severe during sleep as well as multi-system dysregulation of autonomic functions. Areas covered: In this review, we will discuss how evaluation of the disease-defining PHOX2B gene aids diagnosis and helps prognosticate disease severity, review disease physiology, describe clinical presentation and various aspects of autonomic nervous system dysregulation, review ventilatory strategies, and highlight current challenges in the care of these complex patients. Expert commentary: CCHS is a rare disorder that requires a high degree of vigilance. PHOX2B mutation is essential for diagnosis and also helps direct disease management. There is currently no pharmacologic treatment proven effective in improving disease-related hypoventilation and care is focused on providing adequate ventilatory support and managing autonomic dysfunction.
- 19 February 2018
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- Vol. 12 (4) , 283-292
Congenital central hypoventilation syndrome: diagnosis and management
Introduction: Congenital central hypoventilation syndrome (CCHS) is a rare disorder defined by a failure in autonomic control of breathing secondary to mutations of the PHOX2B gene. Affected individuals demonstrate absent or diminished physiologic response to hypercapnia and hypoxia that is most severe during sleep as well as multi-system dysregulation of autonomic functions. Areas covered: In this review, we will discuss how evaluation of the disease-defining PHOX2B gene aids diagnosis and helps prognosticate disease severity, review disease physiology, describe clinical presentation and various aspects of autonomic nervous system dysregulation, review ventilatory strategies, and highlight current challenges in the care of these complex patients. Expert commentary: CCHS is a rare disorder that requires a high degree of vigilance. PHOX2B mutation is essential for diagnosis and also helps direct disease management. There is currently no pharmacologic treatment proven effective in improving disease-related hypoventilation and care is focused on providing adequate ventilatory support and managing autonomic dysfunction.
- Open Access
- 28 March 2015
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 14 (6) , 714-719
Benign outcome among positive cystic fibrosis newborn screen children with non-CF-causing variants
- 28 March 2015
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 14 (6) , 714-719
Open AccessBenign outcome among positive cystic fibrosis newborn screen children with non-CF-causing variants
- 9 February 2010
- Published by Wiley in Pediatric Pulmonology
- Vol. 45 (3) , 270-274
How much do primary care givers know about tracheostomy and home ventilator emergency care?
Children on home mechanical ventilation are a high‐risk population. How much do primary caregivers (PC) know about handling unexpected situations with tracheostomies or malfunction of their ventilators? To answer this, we prospectively studied the knowledge of 152 PC (108 parents and 44 nurses), using a 25‐question survey regarding emergency situations at home. Results: their mean score was 20.2 correct answers (81%). However, 96 PC (63%) did not know that the low pressure ventilator alarm would not sound if the tracheostomy tube decannulated while still connected to the ventilator. Seventy‐nine PC (52%) failed to understand high pressure alarms sound and mucous plugging. Sixty‐six PC (43%) did not know how much power a battery stored after the suction machine was fully charged. Sixty‐one PC (40%) did not know when the low pressure or low minute volume alarm sounds. Fifty‐six PC (37%) relied on the ventilator alarm to determine the presence of mucous plugs. There were no significant differences in the scores of PC who used continuous flow ventilators, nor in English‐speaking PC versus Spanish‐speaking PC. The experience of the PC did not make a difference in their knowledge of HMV emergency care. Having professional training did not pose an advantage in the score for nurses. We conclude that most PC had a good understanding of emergency care. We speculate that more in depth education on the technical aspects of ventilator alarms and tracheal mucous plugging may help to reduce or prevent emergencies of children on HMV. Pediatr Pulmonol. 2010; 45:270–274.
- 9 February 2010
- Published by Wiley in Pediatric Pulmonology
- Vol. 45 (3) , 270-274
How much do primary care givers know about tracheostomy and home ventilator emergency care?
Children on home mechanical ventilation are a high‐risk population. How much do primary caregivers (PC) know about handling unexpected situations with tracheostomies or malfunction of their ventilators? To answer this, we prospectively studied the knowledge of 152 PC (108 parents and 44 nurses), using a 25‐question survey regarding emergency situations at home. Results: their mean score was 20.2 correct answers (81%). However, 96 PC (63%) did not know that the low pressure ventilator alarm would not sound if the tracheostomy tube decannulated while still connected to the ventilator. Seventy‐nine PC (52%) failed to understand high pressure alarms sound and mucous plugging. Sixty‐six PC (43%) did not know how much power a battery stored after the suction machine was fully charged. Sixty‐one PC (40%) did not know when the low pressure or low minute volume alarm sounds. Fifty‐six PC (37%) relied on the ventilator alarm to determine the presence of mucous plugs. There were no significant differences in the scores of PC who used continuous flow ventilators, nor in English‐speaking PC versus Spanish‐speaking PC. The experience of the PC did not make a difference in their knowledge of HMV emergency care. Having professional training did not pose an advantage in the score for nurses. We conclude that most PC had a good understanding of emergency care. We speculate that more in depth education on the technical aspects of ventilator alarms and tracheal mucous plugging may help to reduce or prevent emergencies of children on HMV. Pediatr Pulmonol. 2010; 45:270–274.
- 15 January 2010
- Published by Wiley in Pediatric Pulmonology
- Vol. 45 (2) , 135-140
Does the 6‐min walk test correlate with the exercise stress test in children?
Is there a correlation between the 6‐min walk and aerobic fitness in children? We studied healthy and cystic fibrosis (CF) subjects age 8–20 years using the 6‐min walk test, treadmill graded exercise stress test, and spirometry. Six‐minute walk distance (6MWD) and the product of 6MWD and body weight (6MWORK) were related to aerobic capacity. Data were analyzed using Student's t‐test and Pearson correlation. 13 healthy subjects [9 females, mean age 15.8 ± 3.6 years, % predicted forced expiratory volume in one second (FEV1) 105 ± 12%, 6MWD 557 ± 73 m, peak oxygen uptake (${\rm V'}_{{\rm O}_2 }$ max) 41.4 ± 7.2 ml/kg/min, and heart rate (HR) at ${\rm V'}_{{\rm O}_2 }$ max 180 ± 10] and 11 CF subjects (3 females, mean age 14.3 ± 3.8 years, FEV1 67 ± 25.9%, 6MWD 468 ± 68 m, ${\rm V'}_{{\rm O}_2 }$ max 27.0 ± 8.1 ml/kg, and HR at ${\rm V'}_{{\rm O}_2 }$ max 163 ± 22] were studied. 6MWD correlates with ${\rm V'}_{{\rm O}_2 }$ max in normal subjects (r = 0.59, P < 0.05) but not in CF subjects (r = 0.09, NS). 6MWORK correlates with ${\rm V'}_{{\rm O}_2 }$ max in CF subjects (r = 0.65, P < 0.05) but not in normal subjects (r = 0.278, NS). We conclude that the 6MWD corresponds with aerobic fitness in normal pediatric subjects and 6MWORK corresponds with aerobic fitness in CF subjects. We speculate that 6MWORK is superior to 6MWD for assessment of aerobic fitness in children with CF. Pediatr Pulmonol. 2010; 45:135–140.- 15 January 2010
- Published by Wiley in Pediatric Pulmonology
- Vol. 45 (2) , 135-140
Does the 6‐min walk test correlate with the exercise stress test in children?
Is there a correlation between the 6‐min walk and aerobic fitness in children? We studied healthy and cystic fibrosis (CF) subjects age 8–20 years using the 6‐min walk test, treadmill graded exercise stress test, and spirometry. Six‐minute walk distance (6MWD) and the product of 6MWD and body weight (6MWORK) were related to aerobic capacity. Data were analyzed using Student's t‐test and Pearson correlation. 13 healthy subjects [9 females, mean age 15.8 ± 3.6 years, % predicted forced expiratory volume in one second (FEV1) 105 ± 12%, 6MWD 557 ± 73 m, peak oxygen uptake (${\rm V'}_{{\rm O}_2 }$ max) 41.4 ± 7.2 ml/kg/min, and heart rate (HR) at ${\rm V'}_{{\rm O}_2 }$ max 180 ± 10] and 11 CF subjects (3 females, mean age 14.3 ± 3.8 years, FEV1 67 ± 25.9%, 6MWD 468 ± 68 m, ${\rm V'}_{{\rm O}_2 }$ max 27.0 ± 8.1 ml/kg, and HR at ${\rm V'}_{{\rm O}_2 }$ max 163 ± 22] were studied. 6MWD correlates with ${\rm V'}_{{\rm O}_2 }$ max in normal subjects (r = 0.59, P < 0.05) but not in CF subjects (r = 0.09, NS). 6MWORK correlates with ${\rm V'}_{{\rm O}_2 }$ max in CF subjects (r = 0.65, P < 0.05) but not in normal subjects (r = 0.278, NS). We conclude that the 6MWD corresponds with aerobic fitness in normal pediatric subjects and 6MWORK corresponds with aerobic fitness in CF subjects. We speculate that 6MWORK is superior to 6MWD for assessment of aerobic fitness in children with CF. Pediatr Pulmonol. 2010; 45:135–140.- 4 November 2005
- Published by Wiley
- p. 517-527
Congenital Syndromes Affecting Respiratory Control during Sleep
- 4 November 2005
- Published by Wiley
- p. 517-527
Congenital Syndromes Affecting Respiratory Control during Sleep